Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
IKT —
INHIBIKASE THERAPEUTICS INC
CUSIP: 45719W205 · Held by 1 superinvestor · Combined value: $2,549,441
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Ken Griffin | 0.0% | $2,549,441 | 1,243,630 | ADD | +1,171,960 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | ADD | +1,171,960 | +1635.2% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | NEW BUY | +71,670 | New |
Who Owns IKT? Superinvestor Holdings
INHIBIKASE THERAPEUTICS INC is held by 1 tracked superinvestor, with a combined position value of $3 million . The largest positions are held by Ken Griffin (0.0% of portfolio).
In the most recent quarter, 1 superinvestor added or initiated positions.